Skip to main content

Table 1 Comparison of our tumor incidence rate study with Horoszewicz’s

From: Testosterone inhibits the growth of prostate cancer xenografts in nude mice

Horoszewicz’s study groups

Our study arms

Serum T

ng/ml

Tumor incidence rate

A. control

 

1.90

62% (18/29)

 

1. Control

1.00

50% (25/50)

B. Castrated

 

<0.10

22% (7/32)

 

2. Castrated

0.10

8% (4/50)

C. Castrated +2 mg T

 

0.45

57% (8/14)

 

3. Normal +2 mg T

2.4 for 2 wks (see Fig. 1)

44% (22/50)

 

4. Normal +5 mg T

2.4 for 5 wks (see Fig. 1)

24% (12/50)